Sino Biopharma makes $100m debut via three
Sino Biopharmaceutical has made its debut in the syndicated loan market by launching a $100m three year financing, with confidence high that the deal will sail through thanks to the group’s strong financials.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts